Roger Song
Stock Analyst at Jefferies
(0.78)
# 3,652
Out of 4,828 analysts
46
Total ratings
28.95%
Success rate
-26.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $40 → $45 | $26.06 | +72.68% | 2 | Apr 29, 2025 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $1 → $2 | $0.59 | +239.73% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $2.55 | +135.29% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $1.82 | +284.62% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $132.18 | +85.35% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $6.59 | +294.84% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.13 | +76.99% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $4.03 | +73.70% | 2 | Dec 9, 2024 | |
| REPL Replimune Group | Maintains: Buy | $16 → $19 | $7.71 | +146.43% | 1 | Dec 4, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $28 | $5.76 | +386.11% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $1.26 | +455.56% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $44.45 | +100.25% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $5.98 | +318.41% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $9.50 | +331.58% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $9.06 | +286.31% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.28 | +174.39% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $31.16 | +313.99% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $0.93 | +761.70% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $69.85 | +38.87% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $15.10 | +376.82% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $27.55 | +299.27% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $5.59 | +526.12% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.80 | +1,022.05% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $4.43 | +80.59% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $0.24 | +1,565.28% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.87 | +2,309.64% | 1 | Sep 2, 2020 |
Kiniksa Pharmaceuticals International,
Apr 29, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $26.06
Upside: +72.68%
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $1 → $2
Current: $0.59
Upside: +239.73%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $2.55
Upside: +135.29%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $1.82
Upside: +284.62%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $132.18
Upside: +85.35%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $6.59
Upside: +294.84%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.13
Upside: +76.99%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $4.03
Upside: +73.70%
Replimune Group
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $7.71
Upside: +146.43%
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $5.76
Upside: +386.11%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.26
Upside: +455.56%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $44.45
Upside: +100.25%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $5.98
Upside: +318.41%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $9.50
Upside: +331.58%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $9.06
Upside: +286.31%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $3.28
Upside: +174.39%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $31.16
Upside: +313.99%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $0.93
Upside: +761.70%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $69.85
Upside: +38.87%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $15.10
Upside: +376.82%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $27.55
Upside: +299.27%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $5.59
Upside: +526.12%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.80
Upside: +1,022.05%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $4.43
Upside: +80.59%
Nov 12, 2021
Upgrades: Buy
Price Target: $3 → $4
Current: $0.24
Upside: +1,565.28%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.87
Upside: +2,309.64%